832 Results

People

  1. Pfister
    Pfister
  2. Lee
    Lee
  3. Sherman
    Sherman
  4. Riaz
    Riaz
  5. Dunn
    Dunn
  6. Wong
    Wong
  7. Ho
    Ho
  8. McBride
    McBride
  9. Shah
    Shah
  10. Tsai
    Tsai

Groups

  1. Head and Neck Service (832)
  2. Solid Tumor Oncology Division (832)
  3. Department of Medicine (826)
  4. Surgery (358)
  5. Radiation Oncology, Department of (310)
  6. Survivorship Research (310)
  7. Center for Pancreatic Cancer Research (173)
  8. Epidemiology and Biostatistics (162)
  9. Weinberg Fellows (161)
  10. Department of Pathology and Laboratory Medicine (155)
  1. "Head and Neck Service"
Formats
  1. Journal Article (407)
  2. Meeting Abstract (360)
  3. Book Section (20)
  4. Review (19)
  5. Editorial (7)
  6. Guidelines (7)
  7. Research Letter (6)
  8. Correspondence (3)
  9. Book Whole (1)
  10. Conference Paper (1)
  11. Miscellaneous (1)
Groups
  1. Head and Neck Service (832)
  2. Solid Tumor Oncology Division (832)
  3. Department of Medicine (826)
  4. Surgery (358)
  5. Radiation Oncology, Department of (310)
  6. Survivorship Research (310)

More Groups

People
  1. David Pfister (389)
  2. Eric Sherman (339)
  3. Nancy Lee (266)
  4. Alan Ho (238)
  5. Nadeem Riaz (159)
  6. Lara Dunn (141)

More People

Years
  1. 2025 (12)
  2. 2024 (72)
  3. 2023 (55)
  4. 2022 (57)
  5. 2021 (58)
  6. 2020 (66)

More Years

Publications
  1. Journal of Clinical Oncology (205)
  2. International Journal of Radiation Oncology, Biology, Physics (140)
  3. Annals of Oncology (43)
  4. Cancer (33)
  5. Head & Neck (28)
  6. Journal of the National Comprehensive Cancer Network (28)

More Publications

Publishers
  1. American Society of Clinical Oncology (219)
  2. Elsevier Inc. (176)
  3. Wiley Blackwell (55)
  4. Oxford University Press (53)
  5. American Association for Cancer Research (46)
  6. Harborside Press (28)

More Publishers

Results (832)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of lenvatinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Tran, C.; Katabi, N.; Ni, A.; Haque, S.; Pfister, D. G.; Ho, A. L.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Combination of dabrafenib (DAB) and lapatinib (LAP) for the treatment of BRAF-mutant thyroid cancer
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Fagin, J. A.; Haque, S.; Robinson, C.; Ghossein, R. A.; Chen, H. X.; Pfister, D. G.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Primary analysis of phase 2 results for cemiplimab, a human monoclonal anti-PD-1, in patients with metastatic cutaneous squamous cell carcinoma (mCSCC)
    Meeting Abstract

    Rischin, D.; Migden, M. R.; Chang, A.; Chung, C. H.; Dunn, L.; Guminski, A.; Hauschild, A.; Hernandez-Aya, L.; Hughes, B. G. M.; Lewis, K. D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Detection and clearance of RET variants in plasma cell free DNA (cfDNA) from patients (pts) treated with LOXO-292
    Meeting Abstract

    Oxnard, G. R.; Drilon, A. E.; Shah, M. H.; Wirth, L. J.; Bauer, T. M.; Velcheti, V.; Lakhani, N. J.; Besse, B.; Park, K.; Patel, J. D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Radiotherapy to demonstrate persistent overall survival benefit in locally advanced or metastatic anaplastic thyroid cancer
    Meeting Abstract

    Ma, J.; Bell, A. C.; Lok, B. H.; Leeman, J. E.; Anderson, E. S.; Riaz, N.; McBride, S. M.; Ganly, I.; Shaha, A. R.; Sherman, E. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1/2 precision medicine study of the next-generation BRAF inhibitor PLX8394
    Meeting Abstract

    Janku, F.; Vaishampayan, U. N.; Khemka, V.; Bhatty, M.; Sherman, E. J.; Tao, J.; Whisenant, J. R.; Hong, D. S.; Bui, N.; Kummar, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Genetic variants including microsatellite instability in metastatic Hürthle cell carcinoma of the thyroid
    Meeting Abstract

    Hale-Wallace, N.; Deshpande, H. A.; Holt, E. H.; Callender, G. G.; Gibson, C.; Lee, G.; Carling, T.; Ho, A. L.; Eder, J. P.; Finberg, K. E.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    McBride, S. M.; Sherman, E. J.; Tsai, C. J.; Baxi, S. S.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D. C.; Michel, L. S.; Spielsinger, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Biomarkers predictive of response to pembrolizumab in head and neck cancer (HNSCC)
    Meeting Abstract

    Seiwert, T.; Haddad, R.; Bauml, J.; Weiss, J.; Pfister, D. G.; Gupta, S.; Mehra, R.; Gluck, I.; Kang, H.; Worden, F.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save